Vitamin D Research Today is a free monthly online journal that collates and summarizes the latest research about Vitamin D, including details on sources, melanin, benefits, deficiency, supplements, calcium absorption.

Volume 8 (2011), Issue 1 (January)

1. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma.
   Pediatrics, 127(1): e180-7. [Abstract] [Full-text]
2. Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs.
   Cancer Chemother Pharmacol, 67(1): 165-71. [Abstract] [Full-text]
3. Enantioselective synthesis of A key A-ring intermediate for the preparation of 1α,25-dihydroxyvitamin D(3).
   Org Lett, 13(1): 86-9. [Abstract] [Full-text]
4. Proceedings of the Rank Forum on Vitamin D.
   Br J Nutr, 105(1): 144-56. [Abstract] [Full-text]
5. Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation.
   Br J Nutr, 105(1): 71-9. [Abstract] [Full-text]
6. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
   J Neurol Neurosurg Psychiatry, 82(2): 189-95. [Abstract] [Full-text]
7. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
   J Neurol Neurosurg Psychiatry, 82(2): 189-95. [Abstract] [Full-text]
8. 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D.
   Arch Biochem Biophys, 505(2): 226-30. [Abstract] [Full-text]
9. Confirmed hypertension and plasma 25(OH)D concentrations amongst elderly men.
   J Intern Med, 269(2): 211-8. [Abstract] [Full-text]
10. Confirmed hypertension and plasma 25(OH)D concentrations amongst elderly men.
    J Intern Med, 269(2): 211-8. [Abstract] [Full-text]
11. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia?
    Toxicol Lett, 200(3): 146-53. [Abstract] [Full-text]
12. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia?
    Toxicol Lett, 200(3): 146-53. [Abstract] [Full-text]
13. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.
    Lancet, 377(9761): 242-50. [Abstract] [Full-text]
14. Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study.
    Transplantation, 91(2): 207-12. [Abstract] [Full-text]
15. Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree.
    J Nutr, 141(2): 290-5. [Abstract] [Full-text]
16. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.
    Prostate, 71(4): 368-72. [Abstract] [Full-text]
17. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.
    Prostate, 71(4): 368-72. [Abstract] [Full-text]
18. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.
    Prostate, 71(4): 368-72. [Abstract] [Full-text]
19. Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries.
    Scand J Public Health, 39(1): 70-8. [Abstract] [Full-text]
20. Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D.
    Am J Med Sci, 341(2): 113-8. [Abstract] [Full-text]
21. Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.
    Int J Cancer, 128(7): 1741-6. [Abstract] [Full-text]
22. Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk.
    Int J Cancer, 128(6): 1425-33. [Abstract] [Full-text]
23. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
    Int J Cancer, 128(6): 1414-24. [Abstract] [Full-text]
24. Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.
    Int J Cancer, 128(7): 1741-6. [Abstract] [Full-text]
25. Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk.
    Int J Cancer, 128(6): 1425-33. [Abstract] [Full-text]
26. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
    Int J Cancer, 128(6): 1414-24. [Abstract] [Full-text]
27. Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.
    Int J Cancer, 128(7): 1741-6. [Abstract] [Full-text]

© 2004-2012 Vitamin D Research Today. All Rights Reserved.